These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3108550)

  • 1. Screening for antibodies to HTLV-III/LAV in our population. A word of caution.
    Zafar MN
    J Pak Med Assoc; 1987 Apr; 37(4):84-5. PubMed ID: 3108550
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of LAV/HTLV-III-positive blood donors.
    Laufs R
    Haematol Blood Transfus; 1987; 31():434-5. PubMed ID: 3481760
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary serological screening of the infection caused by the LAV/HTLV-III/HIV virus in Moscow].
    Pokrovskiĭ VV; Iankina ZK; Toporovskiĭ LM; Ryvkina VG; Pokrovskiĭ VI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):21-3. PubMed ID: 2445129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for anti-HTLV-III/LAV antibody in high-risk subjects: sensitivity and specificity of commercial tests.
    Lantin JP; Peitrequin R; Frei PC
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):487-9. PubMed ID: 3553029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-LAV/HTLV-III antibodies in high and low risk groups.
    Zanetti AR; Zehender G; Tanzi E; Rumi MG; Mari D; Ferroni P
    Antibiot Chemother (1971); 1987; 38():167-73. PubMed ID: 3310859
    [No Abstract]   [Full Text] [Related]  

  • 6. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria.
    Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G
    Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
    Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y
    Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphopathic HTLV-III-LAV infection and acquired immunodeficiency syndrome].
    Pokrovskiĭ VV
    Ter Arkh; 1986; 58(10):151-4. PubMed ID: 3541273
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-III infection in the RSA.
    Becker WB
    S Afr Med J; 1986 Oct; Suppl():26-7. PubMed ID: 3535115
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of ELISA in the diagnosis of HTLV-III-LAV infection. Specificity of kits].
    Lazizi Y; Guetard D; Pillot J
    Presse Med; 1986 Dec; 15(43):2169. PubMed ID: 2954072
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
    Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
    Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HTLV-III/LAV antibodies among Haitians.
    Pitchenik AE; Spira TJ; Elie R; Fischl MA; Getchell JP; Arnoux E; Pierre GD; Laroche AC; Guerin JM; Malebranche R
    N Engl J Med; 1985 Jun; 312(26):1705-6. PubMed ID: 3858670
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.
    Schüpbach J; Tanner M
    Acta Trop; 1986 Sep; 43(3):195-206. PubMed ID: 2877546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-LAV/HTLV III antibodies in patients under hemodialysis receiving blood transfusion protocols. A retrospective study of 2 transplant centers].
    Ferec C; Deroff P; Bourbigot B; Herve JP; Le Guy P; Bignon JD; Boudard D; Soulillou JP
    Presse Med; 1986 Sep; 15(29):1378. PubMed ID: 2950422
    [No Abstract]   [Full Text] [Related]  

  • 20. [LAV/HTLV-III infection among a group of homosexual men; prevalence and psychosocial factors].
    van Griensven GJ; Tielman RA; Goudsmit J; van der Noordaa J; de Wolf F; Coutinho RA
    Ned Tijdschr Geneeskd; 1986 Nov; 130(48):2178-80. PubMed ID: 3492678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.